Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Growth Inhibition of Human MDA-MB-231 Breast Cancer Cells by δ-Tocotrienol Is Associated with Loss of Cyclin D1/CDK4 Expression and Accompanying Changes in the State of Phosphorylation of the Retinoblastoma Tumor Suppressor Gene Product

SELVAKUMAR ELANGOVAN, TZE-CHEN HSIEH and JOSEPH M. WU
Anticancer Research September 2008, 28 (5A) 2641-2647;
SELVAKUMAR ELANGOVAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TZE-CHEN HSIEH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOSEPH M. WU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Joseph_Wu{at}nymc.edu
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 28 no. 5A 2641-2647
PMID 
19035289

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received April 18, 2008
  • Revision received June 5, 2008
  • Accepted June 17, 2008
  • Published online September 1, 2008.

Copyright & Usage 
Copyright© 2008 International Institute of Anticaner Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. SELVAKUMAR ELANGOVAN,
  2. TZE-CHEN HSIEH and
  3. JOSEPH M. WU
  1. Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY 10595, U.S.A.
  1. Correspondence to: Professor Dr. Joseph M. Wu, Room 147, Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY 10595, U.S.A. Tel: +1 9145944891, Fax: +1 9145944058, e-mail: Joseph_Wu{at}nymc.edu

Statistics from Altmetric.com

Cited By...

  • 40 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 28, Issue 5A
September-October 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Growth Inhibition of Human MDA-MB-231 Breast Cancer Cells by δ-Tocotrienol Is Associated with Loss of Cyclin D1/CDK4 Expression and Accompanying Changes in the State of Phosphorylation of the Retinoblastoma Tumor Suppressor Gene Product
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Growth Inhibition of Human MDA-MB-231 Breast Cancer Cells by δ-Tocotrienol Is Associated with Loss of Cyclin D1/CDK4 Expression and Accompanying Changes in the State of Phosphorylation of the Retinoblastoma Tumor Suppressor Gene Product
SELVAKUMAR ELANGOVAN, TZE-CHEN HSIEH, JOSEPH M. WU
Anticancer Research Sep 2008, 28 (5A) 2641-2647;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Growth Inhibition of Human MDA-MB-231 Breast Cancer Cells by δ-Tocotrienol Is Associated with Loss of Cyclin D1/CDK4 Expression and Accompanying Changes in the State of Phosphorylation of the Retinoblastoma Tumor Suppressor Gene Product
SELVAKUMAR ELANGOVAN, TZE-CHEN HSIEH, JOSEPH M. WU
Anticancer Research Sep 2008, 28 (5A) 2641-2647;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • d-{delta}-Tocotrienol-mediated Cell Cycle Arrest and Apoptosis in Human Melanoma Cells
  • 7,3',4'-Trihydroxyisoflavone Inhibits Epidermal Growth Factor-induced Proliferation and Transformation of JB6 P+ Mouse Epidermal Cells by Suppressing Cyclin-dependent Kinases and Phosphatidylinositol 3-Kinase
  • {gamma}-Tocotrienol Controls Proliferation, Modulates Expression of Cell Cycle Regulatory Proteins and Up-regulates Quinone Reductase NQO2 in MCF-7 Breast Cancer Cells
  • Google Scholar

More in this TOC Section

  • Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase In Vitro
  • Synergistic Effects of Honokiol on Camptothecin-triggered Apoptosis of Drug-resistant Glioblastoma Cells via CDK1-mediated G2/M Arrest and Intrinsic ROS-Mitochondrion-dependent Pathway
  • Amlodipine Suppresses Lung Metastasis by Increasing Cell Stiffness
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire